Summary & Overview
HCPCS G9278: Documentation of No Daily Aspirin or Antiplatelet Regimen
HCPCS Level II code G9278 is used to document that a patient is not taking a daily aspirin or other antiplatelet medication. This documentation is important for peri-procedural planning, medication reconciliation, and clinical risk assessment, and it supports accurate medical records and patient safety. Nationally, clear documentation of antiplatelet use or non-use affects clinical decision-making and may influence billing and quality measurement processes.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what G9278 represents, the clinical contexts where it is most applicable, and which payers commonly recognize or cover documentation elements related to antiplatelet medication status. The publication also outlines where to find related billing guidance, common modifiers, and how G9278 fits into medication reconciliation workflows and pre-procedure evaluations. Data not available in the input is noted where payer-specific coverage details, associated taxonomies, ICD-10 pairings, and related codes would normally appear.
Billing Code Overview
HCPCS Level II code G9278 documents that the patient is not on a daily aspirin or antiplatelet regimen. This service represents a clinical documentation entry confirming the absence of routine antiplatelet therapy.
-
Service type: Medication reconciliation / clinical documentation
-
Typical site of service: Outpatient clinic, physician office, pre-procedure assessment, or other ambulatory care settings where medication status is reviewed
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult scheduled for a surgical or invasive procedure (for example, ophthalmic surgery, dermatologic excision, or interventional radiology procedure) who requires documentation of current antiplatelet therapy status. A preoperative nurse or clinician interviews the patient during the preoperative assessment or on the day of service and documents that the patient is not taking daily aspirin or any antiplatelet agents. The documentation is placed in the medical record and often incorporated into the pre-anesthesia evaluation, surgical consent, and the procedure note. This billing descriptor supports reporting that the patient is not on a daily aspirin/antiplatelet regimen to inform peri-procedural bleeding risk and medication management decisions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation shows substantially greater work than typical for preoperative medication reconciliation tasks tied to the encounter. |
23 | Unusual anesthesia | Use when general anesthesia is provided for a procedure that normally requires local/regional anesthesia and medication reconciliation impacts anesthesia planning. |